Company Overview: NovoCure Limited (NASDAQ: NVCR) is engaged in developing and commercializing Tumor Treating Fields (TTFields) therapy for the treatment of aggressive cancers. Its products include Optune Gio and Optune Lua, primarily marketed in the United States, Germany, France, and Japan.
Rec...